348 related articles for article (PubMed ID: 21613219)
1. Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival.
Kato H; Gruenwald A; Suh JH; Miner JH; Barisoni-Thomas L; Taketo MM; Faul C; Millar SE; Holzman LB; Susztak K
J Biol Chem; 2011 Jul; 286(29):26003-15. PubMed ID: 21613219
[TBL] [Abstract][Full Text] [Related]
2. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
3. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
Li Z; Xu J; Xu P; Liu S; Yang Z
Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
[TBL] [Abstract][Full Text] [Related]
5. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/β-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria.
Jiang L; Xu L; Song Y; Li J; Mao J; Zhao AZ; He W; Yang J; Dai C
J Biol Chem; 2013 Aug; 288(32):23368-79. PubMed ID: 23803607
[TBL] [Abstract][Full Text] [Related]
7. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
Wang Y; Li H; Song SP
Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435
[TBL] [Abstract][Full Text] [Related]
8. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.
Hu M; Wang R; Li X; Fan M; Lin J; Zhen J; Chen L; Lv Z
J Cell Mol Med; 2017 Nov; 21(11):2732-2747. PubMed ID: 28444861
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria.
Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y
Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone is involved in the pathogenesis of obesity-related glomerulopathy through activation of Wnt/β-catenin signaling in podocytes.
Zhu JJ; Chen YP; Yang M; Liu BL; Dong J; Dong HR; Rui HL; Cheng H
Mol Med Rep; 2018 Mar; 17(3):4589-4598. PubMed ID: 29328453
[TBL] [Abstract][Full Text] [Related]
12. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
Lenoir O; Milon M; Virsolvy A; Hénique C; Schmitt A; Massé JM; Kotelevtsev Y; Yanagisawa M; Webb DJ; Richard S; Tharaux PL
J Am Soc Nephrol; 2014 May; 25(5):1050-62. PubMed ID: 24722437
[TBL] [Abstract][Full Text] [Related]
13. Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
Zhou D; Wang Y; Gui Y; Fu H; Zhou S; Wang Y; Bastacky SI; Stolz DB; Liu Y
Kidney Int; 2022 Jul; 102(1):96-107. PubMed ID: 35341792
[TBL] [Abstract][Full Text] [Related]
14. A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane.
Ishikawa T; Takemoto M; Akimoto Y; Takada-Watanabe A; Yan K; Sakamoto K; Maezawa Y; Suguro M; He L; Tryggvason K; Betsholtz C; Yokote K
J Mol Med (Berl); 2021 Jun; 99(6):859-876. PubMed ID: 33620517
[TBL] [Abstract][Full Text] [Related]
15. Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.
Wang D; Dai C; Li Y; Liu Y
Kidney Int; 2011 Dec; 80(11):1159-1169. PubMed ID: 21832980
[TBL] [Abstract][Full Text] [Related]
16. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
Fu J; Lee K; Chuang PY; Liu Z; He JC
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
[TBL] [Abstract][Full Text] [Related]
17. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling.
Shkreli M; Sarin KY; Pech MF; Papeta N; Chang W; Brockman SA; Cheung P; Lee E; Kuhnert F; Olson JL; Kuo CJ; Gharavi AG; D'Agati VD; Artandi SE
Nat Med; 2011 Dec; 18(1):111-9. PubMed ID: 22138751
[TBL] [Abstract][Full Text] [Related]
18. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
19. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine is Involved in Lipopolysaccharide-Induced Podocyte Injury through the Wnt/β-Catenin Pathway in an Acute Kidney Injury Mouse Model.
Senouthai S; Wang J; Fu D; You Y
Inflammation; 2019 Aug; 42(4):1287-1300. PubMed ID: 30919150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
